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Toxoplasma gondii Strains Defective in Oral Transmission Are Also
Defective in Developmental Stage Differentiation
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Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110,1 and
Department of Microbiology, University of Tennessee, Knoxville, Tennessee 379962
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Toxoplasma gondii undergoes differentiation from rapidly growing tachyzoites to slowly growing bradyzoites
during its life cycle in the intermediate host, and conversion can be induced in vitro by stress. Representative
strains of the three clonal lineages showed equal capacity to differentiate into bradyzoites in vitro, as evidenced
by induction of bradyzoite antigen 1, staining with Dolichos biflorus lectin (DBL), pepsin resistance, and oral
infectivity in mice. We also examined several recently described exotic strains of T. gondii, which are genetically
diverse and have a different ancestry from the clonal lineages. The exotic strain COUG was essentially like the
clonal lineages and showed a high capacity to induce bradyzoites in vitro and in vivo, consistent with its ability
to be efficiently transmitted by the oral route. In contrast, exotic strains MAS and FOU, which are defective in
oral transmission, showed a decreased potential to develop into bradyzoites in vitro. This defect was evident
from reduced staining with DBL and the cyst antigen CST1, failure to down-regulate tachyzoite antigens, such
as tachyzoite surface antigens 1 and 2A, and decreased resistance to pepsin treatment. Despite normal in vitro
differentiation, the exotic strains CAST and GPHT also showed decreased oral transmission, due to formation
of smaller cysts and a lower tissue burden during chronic infection, traits also shared by MAS and FOU.
Collectively, these findings reveal that the limited oral transmission in some strains of T. gondii is due to
inefficient differentiation to the bradyzoite form, leading to defects in the formation of tissue cysts.
The protozoan Toxoplasma gondii is one of the most suc-
cessful parasites of vertebrates, capable of infecting a wide
range of warm-blooded hosts, including humans. It is esti-
mated that more than one quarter of the human population
worldwide is infected (26). The ingestion of food or water
contaminated with oocysts from cat feces or ingestion of tissue
cysts in undercooked meat are the two major routes of human
infection (12, 19). In North America and Europe, T. gondii has
a highly clonal population structure comprised of three wide-
spread and similar lineages referred to as types I, II, and III (2,
11, 25, 35). More than 95% of the strains from these regions
can be classified into one of these highly clonal lineages. This
marked clonality is evidence of a rapid expansion following a
severe genetic bottleneck that is estimated to have occurred
circa 10,000 years ago (23, 39).
Following infection of intermediate hosts with T. gondii, the
parasite initially multiplies in the fast-growing tachyzoite stage
before differentiating into the slowly replicating form called
the bradyzoite (20). Unlike tachyzoites, bradyzoites are rela-
tively resistant to gastric digestion (i.e., pepsin) (17) and thus
are infectious orally both to cats, the definitive host, and to
other intermediate hosts (12). Cats are very sensitive to infec-
tion by bradyzoites, while generally 1,000 bradyzoites are
needed for consistent infection of mice by the oral route (14).
Bradyzoite transmission between intermediate hosts may be
important for spread through the food chain via carnivorous
feeding or scavenging, thus bypassing the need for the cat.
Direct oral transmission between intermediate hosts is unique
to T. gondii and is not present in related parasites such as
Neospora spp. and Hammondia spp. (18).
Direct oral transmission between intermediate hosts is a
common feature of the clonal lineages of T. gondii, and this
may have contributed to their rapid expansion and successful
spread (39). While clonality is the predominant pattern in T.
gondii in North America and Europe, occasionally recombi-
nant strains or those with more exotic genotypes are encoun-
tered (2, 25). It has been suggested that such exotic lineages
represent the genetic makeup of strains isolated from geo-
graphically restricted areas (1). Examination of several exotic
lineages previously indicated that some of them are defective
in oral transmission between intermediate hosts (39). How-
ever, the underlying molecular basis of the defect in oral trans-
mission of these exotic strains has not been previously defined.
In vitro models of tachyzoite-to-bradyzoite differentiation
have been established using a variety of stress conditions that
mimic the stresses of the host immune response. These condi-
tions include treatment with gamma interferon (5), mitochon-
drial inhibitors (6), alkaline pH (pH 8.1) (38), and high tem-
perature (37). The stress response is controlled in part by
eIF-2k kinase, which is well characterized as a stress response
in eukaryotic cells (41), and differentiation also involves cyclic
nucleotide kinases (21). Microarray studies (9), large-scale se-
quencing of stage-specific cDNA (28, 31), and serial analysis of
gene expression tags (34) reveal that stage conversion involves
changes in the expression of a large number of genes, although
the regulatory mechanism(s) involved in this switch is poorly
understood.
A number of markers have been used to follow stage con-
version, including the decreased expression of tachyzoite sur-
* Corresponding author. Mailing address: Department of Molecular
Microbiology, Washington University School of Medicine, St. Louis,
MO 63110. Phone: (314) 362-8873. Fax: (314) 362-3203. E-mail: sibley
@borcim.wustl.edu.
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face antigen 1 (SAG1) (8) and the concomitant induction of
bradyzoite antigen 1 (BAG1) (45) and lactate dehydrogenase 2
(LDH2) (43). One of the hallmark features of the cyst wall is
positive staining with Dolichos biflorus lectin (DBL) (27),
which recognizes N-acetylgalactosamine. The major DBL-
binding component of the cyst wall has been described as a
116-kDa glycoprotein termed CST1 (44). While the cyst may
present a permeability barrier to drugs and aid in immune
evasion, the composition of the wall is not well understood.
Treatment with acid-pepsin, as occurs in the stomach, dissolves
the cyst wall and liberates bradyzoites, which remain infectious
following this treatment (17).
In the present report, we defined conditions that allow in
vitro development of fully mature bradyzoites as defined by
antigen expression, cell wall composition, pepsin resistance,
and oral infectivity. We then compared the induction of bra-
dyzoite development in clonal and several exotic strains of T.
gondii in order to define the basis of their defects in oral
transmission.
MATERIALS AND METHODS
Parasite strains. We compared representative strains of the clonal lineages
using well-characterized prototypic strains. The GT-1 strain (type I) was isolated
from skeletal muscle of a goat (16). The ME49 strain (type II) (American Type
Culture Collection ATCC 50611) was isolated from the diaphragm of a sheep
(30). The CTG strain (type III) (ATCC 50842) was isolated from oocysts shed
from an infected cat (33). To assure that the full biological capability to differ-
entiate was retained by these representative strain types, isolates were used
within 10 to 20 passages following transmission through a cat. In addition, we
examined a number of exotic strains that do not fit within the clonal lineages,
including MAS (ATCC 50870), isolated from a congenital infection in France
(11); CAST (ATCC 50868), isolated from a patient with HIV in the United
States (35); FOU (ATCC 50869), isolated from a human transplant in France
(11); GPHT, isolated from a human congenital infection in France (10); and
COUG, an isolate from a cougar in British Columbia, Canada (3). Parasites were
propagated in human foreskin fibroblast (HFF) cells grown in Dulbecco’s mod-
ified Eagle medium containing 10% fetal bovine serum (FBS), 10 mM HEPES
(pH 7.4), 1 mM glutamine, 10 g/ml gentamicin, under 5% CO2 at 37°C. While
these other isolates were not passaged through cats, they were used at the lowest
available passage number in vitro, generally less than 10 passages following
infection in rodents.
In vitro differentiation of strains of Toxoplasma gondii. In vitro bradyzoite
induction was performed using alkaline treatment of confluent monolayers of
HFF cells grown in 6-well plates. The plates were infected with tachyzoites of
each strain and differentiation was induced by culture in sodium bicarbonate-free
RPMI 1640 containing 1% FBS, HEPES (pH 8.1) at 37°C without CO2 (38).
Cultures were incubated for 3 to 9 days, with replacement of the medium every
2 to 3 days.
Acid-pepsin digestion. Acid-pepsin solution from porcine stomach (biological
activity, 1:1,000) (Sigma Chemical Co., St. Louis, MO) was used to quantify
bradyzoites produced in cell culture (13). Cysts were treated with 0.26 mg/ml
pepsin, 0.170 M NaCl (pH 1.4) at 37°C for 45 min and then neutralized with 1.2%
sodium bicarbonate (pH 8.3). Pepsin-resistant parasites were quantified by plat-
ing dilutions on HFF monolayers and counting foci or plaques at 7 to 9 days
postinfection.
RNA extraction and cDNA synthesis. Total RNA was isolated from freshly
harvested parasites using TRIzol (Invitrogen Corp., Carlsbad, CA). The total
RNA (1 g per sample) was transcribed into cDNA using 50 M oligo(dT)20 and
200 units of SuperScript III reverse transcriptase (RT) (Invitrogen) in a volume
of 20 l following the manufacturer’s protocol. For negative controls, water was
added instead of RT.
Real-time RT-PCR. PCR primers were designed using Primer Express soft-
ware, version 1.0 (Applied Biosystems, Foster City, CA). Real-time quantitative
PCR (qPCR) was performed using a SmartCycler (Cepheid, Sunnyvale, CA)
with a reaction mixture volume of 25 l containing SYBR greenER qPCR
SuperMix universal (Invitrogen), 400 nM of each primer, and 1 to 2 l of cDNA.
The reaction conditions were 50°C for 2 min, 95°C for 10 min, followed by 40
cycles of 95°C for 15 s and 60°C for 60 s. Nontemplate controls (water blank or
host cell total RNA) were run with every assay and all determinations were
performed in duplicate to ensure reproducibility. Data analysis was conducted
using SmartCycler software (Cepheid). The relative gene expression levels were
calculated as the fold change using the formula 2
CT
, where CT  threshold
cycle (CT) of actin  CT of the target gene (shown in Table 1) and CT  CT
of the tachyzoite stage RNA  CT of the bradyzoite stage RNA (29). The
housekeeping gene encoding actin (ACT1) was used as a reference control.
Immunostaining. HFF cells were grown to confluence on chamber slides
(Labtek, Campbell, CA), infected with parasites, and examined at different
times, 5, 7, and 9 days after bradyzoite induction. For immunofluorescence
assays, parasites were fixed for 15 min in phosphate-buffered saline (PBS) con-
taining 4% paraformaldehyde, permeabilized for 10 min in 1% Triton X-100, and
blocked for 10 min in 5% FBS and 5% normal goat serum. Samples were
incubated for 1 h with monoclonal antibody (mAb) 8.25.8 against BAG1 (42),
mAb DG52 against SAG1, or mAb 73.18 to CST1 (44) diluted 1:1,000 in PBS in
1% FBS. The samples were washed three times and primary antibodies were
detected with goat anti-mouse immunoglobulin G (IgG) conjugated to Alexa 594
(Invitrogen Molecular Probes, Carlsbad, CA) diluted 1:1,000. After being
washed three times, the samples were incubated with fluorescein isothiocyanate-
conjugated DBL diluted 1:1,000 (Sigma, St. Louis, MO). The slides were rinsed
in PBS, mounted with Vectashield (Vector, Burlingame, CA), and analyzed with
a Zeiss AxioSkop wide-field epifluorescence microscope equipped with an Axio-
Cam charge-coupled-device camera. Images were captured using AxioVision
v3.1 (Carl Zeiss Inc., Thornwood, NY). Cells were examined at 40 magnifica-
tion and the average numbers of cysts were determined by counting 10 fields
from duplicate samples. The sizes of the cysts formed in vitro were estimated
using the measurement tool in AxoVision to trace the perimeter and calculate
the area. The experiments were repeated two or more times, and a representative
example is shown.
Oral infection of mice with bradyzoites induced in vitro. Eight-week-old fe-
male CD-1 outbred mice (Charles River Laboratories, Wilmington, MA) were
used for experimental infections. Mice were infected by oral administration of
100, 1,000, or 10,000 cysts of T. gondii developed in vitro (five animals/dose). At
the end of the 30-day observation period, blood samples were collected from
surviving mice, and sera were tested by Western blotting for antibodies against T.
gondii RH strain lysate. Mouse sera were diluted 1:1,000 in PBS containing 1%
nonfat dry milk. Horseradish peroxidase-conjugated goat anti-mouse IgG (Am-
ersham Pharmacia Biotech, Piscataway, NJ) was diluted 1:10,000 and used as the
secondary antibody. Antibody binding was detected by using enhanced chemilu-
minescent substrate (Pierce Biotechnology Inc., Rockford, IL). The percent
cumulative mortality was defined as the number of animals that succumbed to
infection/the total number of infected animals (i.e., deaths plus seropositive
survivors), as described previously (40).
Production of cysts in vivo and challenge in naı¨ve mice. Tachyzoites of T.
gondii strains were propagated in vitro and used to induce chronic infections in
mice or rats by intraperitoneal (i.p.) injection. At 1 to 2 months postinfection, the
animals were sacrificed and the brains were removed and homogenized in PBS.
TABLE 1. Primers used for qPCR in this study
Gene Gene identification no.a Forward primer Reverse primer
ACT1 25.m00007 TCCCGTCTATCGTCGGAAAG CCATTCCGACCATGATACCC
SAG1 44.m00009 ATCGCCTGAGAAGCATCACTG CGAAAATGGAAACGTGACTGG
BAG1 55.m00009 GACGTGGAGTTCGACAGCAAA ATGGCTCCGTTGTCGACTTCT
SAG2A 59.m00008 TGTTTCAGGTTGCTGCAGTGA CAAGCAGCGCTCGTTTTCTT
LDH2 80.m00010 GAAGTGTGCACGCTTTGCAA CAGCCAGTGATGATGCAGCT
a Toxoplasma gondii Genome Resource (http://toxodb.org).
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The numbers of cysts were estimated by counting aliquots of 10 l from a total
volume of 1 ml (mice) or 4 ml (rats). The sizes of the cysts were estimated using
the measurement tool in AxioVision software to determine the diameter, which
was then used to calculate volume using the standard geometric formula for a
sphere. To establish oral transmissibility, cysts were administered orally by a
gastric feeding tube. In parallel, separate groups of animals were injected i.p.
with an equal number of cysts. Survival of the mice was monitored for 30 days,
after which the animals were tested for seroconversion as described above.
Cumulative infectivity was defined as the number of animals succumbing to
infection plus survivors that were seropositive/the total number of animals used
per group (typically 5).
Fluorescent staining of cysts with DBL. Chronically infected animals were
sacrificed 1 month postinfection, and the brains were removed and homoge-
nized in 1 ml of PBS (mice) or 4 ml of PBS (rats). An aliquot of the brain
suspension was fixed in 5% formaldehyde containing 0.2% Triton X-100 in PBS
for 20 min. Cysts were washed in PBS, blocked using a solution of 10% normal
goat serum in PBS, and stained with fluorescein isothiocyanate-labeled DBL.
The suspension was examined using wide-field epifluorescence microscopy, and
the cysts were imaged as described above.
Transmission electron microscopy. For ultrastructural analysis, cysts were
induced for 9 days as described above and fixed in 2% paraformaldehyde–2.5%
glutaraldehyde (Polysciences Inc., Warrington, PA) in 100 mM phosphate buffer
(pH 7.2) for 1 h at room temperature. Following three washes in phosphate
buffer, the cells were postfixed in 1% osmium tetroxide (Polysciences Inc., War-
rington, PA) for 1 h at room temperature. The samples were then rinsed exten-
sively in distilled water prior to en bloc staining with 1% aqueous uranyl acetate
(Ted Pella Inc., Redding, CA) for 1 h at room temperature. Following several
rinses in distilled water, the cells were dehydrated in a graded series of ethanol
dilutions and embedded in Eponate 12 resin (Ted Pella Inc.). Sections of 70 to 80 nm
were cut, stained with uranyl acetate and lead citrate, and viewed on a JEOL 1200
EX transmission electron microscope (JEOL USA, Inc., Peabody, MA).
Animal care and housing. The animals were cared for by the Division of
Comparative Medicine and all procedures conducted here were approved by the
Animal Studies Committee at Washington University.
Statistics. Triplicate experiments were performed and the means and standard
deviations calculated for statistical comparisons. The differences between the
means were compared using Student’s t test.
RESULTS
Induction of bradyzoite or cyst wall antigens following in
vitro culture under stress conditions has previously been used
to define stage conversion in T. gondii (38, 45). Previous studies
have primarily used the type II strain ME49 or clones from this
strain, which are extremely efficient at cyst production in vitro
and in vivo. To determine the relative contribution of the
parasite’s genotype to stage conversion, we evaluated several
prototypical strains of the three clonal lineages of T. gondii. In
addition to evaluating the expression of bradyzoite or cyst wall
antigens, we also tested whether fully mature bradyzoites form
in vitro under stress conditions. Bradyzoite infectivity was eval-
uated based on resistance to acid-pepsin treatment or oral
infection of naı¨ve mice. Finally, we compared the responses of
the well-studied clonal lineages to those of several exotic lin-
eages that have previously been shown to be defective in oral
transmission in the mouse model. Collectively, these studies
define the molecular and cellular basis for the defect in trans-
mission of these naturally occurring strains.
In vitro development of cysts by clonal strains of T. gondii.
We tested the induction of bradyzoites following alkaline pH
stress in vitro by representative strain types of T. gondii. Cyst
conversion was identified by staining with fluorescent DBL
(27) and antibodies specific to the bradyzoite antigen, BAG1
(42). A representative example of the staining for DBL and
BAG1 is shown in Fig. 1A. The numbers of DBL BAG1
cysts were determined and the average sizes of the cysts were
measured at 5, 7, and 9 days after induction (Fig. 1). The
average numbers of cysts were similar for the three strains at
all three time periods of in vitro development (Fig. 1B). Strain
ME49 formed larger cysts than CTG, and the differences were
statistically significant (P  0.05) at day 7 and day 9 (Fig. 1C).
Cysts formed by GT-1 also tended to be smaller than those of
ME49, but due to the higher variance in this group, the differ-
ences were not significant (Fig. 1C). These results reveal that
conversion to cysts, as defined by DBL staining and BAG1
expression, occurs rapidly after in vitro induction among all
three clonal lineages.
FIG. 1. In vitro differentiation to bradyzoites by clonal lineages.
Representative strains for type I (GT-1), type II (ME49), and type III
(CTG) strains were induced to differentiate by high-pH culture for 5,
7, and 9 days. Cyst development was detected by staining with fluo-
resceinated DBL and by using the mAb 8.25.8 to BAG1 followed by
secondary antibodies conjugated to Alexa 594. (A) Representative
example of BAG1 staining (red channel) and DBL-positive staining
(green channel) for in vitro-derived cysts of T. gondii. Nuclei are
stained in blue (DAPI). Scale bar  10 m. (B) The average numbers
of cysts per 40 magnification field were similar among all three
lineages at all time points. (C) Average sizes (area in m2) of cysts
formed by T. gondii strains from the three lineages. ME49 formed the
largest cysts, while cysts formed by GT-1 and CTG were somewhat
smaller. The differences between ME49 and CTG were statistically
significant at day 7 and day 9 (, P  0.05). Error bars show standard
deviations.
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Oral infection of CD-1 mice with in vitro-produced brady-
zoites. To determine whether in vitro-derived cysts were capa-
ble of causing oral infection, we challenged CD-1 mice with
cysts produced by alkaline pH stress. CD-1 mice were orally
challenged with different doses of DBL cysts from the ME49
strain induced in vitro for 5, 7, and 9 days of culture. At 30 days
postinoculation, the number of infected animals was deter-
mined by Western blotting for the detection of antibodies
specific to T. gondii. While the overall oral infectivity of in
vitro-produced cysts was low, it increased approximately 10-
fold between day 5 and 9 (Table 2). By day 9 of culture, more
than half of the mice became infected with a challenge dose of
1,000 cysts (Table 2). Examination of these cysts by 4,6-
diamidino-2-phenylindole (DAPI) staining revealed that they
contained from 10 to 20 nuclei (data not shown). Hence, the
oral dose of 1,000 cysts likely contained 104 total parasites.
To determine the extent of conversion to mature bradyzoites,
we treated in vitro-derived cysts with acid-pepsin for 45 min
and tested their viability by plaquing on host cell monolayers.
These experiments indicated that between 5 and 10% of total
parasites were resistant to acid-pepsin at 9 days postinfection
(Table 3 and data not shown). Collectively, these studies es-
tablish that, following in vitro culture for 9 days, a dose of
1,000 cysts containing 103 acid-pepsin-resistant parasites is
capable of causing oral infection in the mouse.
To determine whether cysts produced by different T. gondii
strains differed in oral infectivity, cysts developed during 9 days
of induction were used to challenge CD-1 mice by the oral
route. All three clonal types showed similar levels of oral
transmissibility in the mouse model (Table 2). Collectively,
these studies show that rapid induction of bradyzoite antigens
occurs following alkaline pH culture and that fully mature
bradyzoites, as defined by oral transmission, are produced by
all three clonal lineages.
In vitro development of cysts by exotic strains of T. gondii.
The previous finding that some exotic strains have reduced oral
transmission in the mouse model (39) suggests that they may
have defects in the development of mature bradyzoites. These
exotic strains were tested in vitro for induction of bradyzoite
antigens following culture at alkaline pH and staining for the
bradyzoite markers BAG1 and DBL. Similar to the clonal
lineages, exotic strains COUG, CAST, and GPHT expressed
BAG1 at high levels by day 5 of culture (Table 3). However,
the strains MAS and FOU displayed much lower levels of
expression of BAG1 (Table 3). A more profound difference
was observed in the staining patterns with DBL. Even among
cysts where BAG1 staining was positive, the exotic strains MAS
and FOU failed to stain appreciably with DBL, while the
remaining exotic and clonal lineages stained strongly (Fig. 2
and Table 3). The exotic strain MAS also stained very weakly
for the cyst wall antigen CST1, even in cysts expressing BAG1,
while the remaining strains stained strongly with this marker
following the induction of bradyzoite development (Fig. 2,
Table 3). The tachyzoite antigen SAG1 is gradually shut off
during in vitro differentiation (38), and consistent with this, a
majority of the vacuoles formed by the clonal lineages failed to
stain with antibodies to SAG1 by day 9 of culture (Table 3). In
contrast, exotic strains MAS and FOU continued to express
high levels of SAG1 (Table 3).
We also compared the induction of bradyzoite differentia-
tion by exotic and clonal-lineage strains using several reference
genes that undergo dramatic changes in gene transcription
during differentiation (4, 9, 43). The tachyzoite-specific genes
SAG1 and SAG2A showed 10- to 100-fold repression during
conversion to bradyzoites in the clonal strain ME49 and the
exotic strain COUG (Fig. 3). In contrast, there was almost no
TABLE 2. Infection of mice challenged by feeding of in
vitro-produced cysts of T. gondii
Strain and no. of
days cultivateda
No. of mice infected/no. of mice challenged
by indicated dose of cystsb
100 1,000 10,000
ME49
5 ND 0/5 2/5
7 0/5 1/5 2/5
9 0/5 3/5 5/5
GT-1
9 0/5 4/5† 2/5†
CTG
9 1/5 2/5 3/5
a Days of in vitro cultivation to induce cysts before infection.
b Infection was determined at 30 days postinoculation by positive Western
blotting of serum against whole tachyzoite antigen. The estimated dose of cysts
is based on DBL-positive staining. ND, not done; †, infected animals died during
the 30-day period.
TABLE 3. Comparisons of in vitro-derived cysts of clonal and exotic strains of T. gondii
Strain Type Host Location % BAG1positivea
% SAG1
positiveb DBL positive
c CST1 positived Pepsinresistant (%)e
GT-1 I Goat United States 100 34.1   9.40
ME49 II Sheep United States 100 34.4   3.40
CTG III Cat United States 100 36.7   4.10
COUG Exotic Cougar Canada 93.3 35.0   6.40
CAST Exotic Human United States 100 31.7   5.03
GPHT Exotic Human France 100 43.9   2.75
MAS Exotic Human France 70.4 75.0 Weak Weak 0.07
FOU Exotic Human France 66.1 100 Weak  0.03
a Percentage of positive vacuoles at day 5 of induction, as detected with mAb 8.25.8 to BAG1.
b Percentage of positive vacuoles at day 9 of induction, as detected with mAb DG52 to SAG1.
c , strongly positive vacuoles at day 5 of induction, as detected with fluorescent DBL.
d , strongly positive vacuoles at day 5 of induction, as detected with mAb 73.18 to CST-1.
e Percentage of total parasites resistant to acid-pepsin treatment at day 9 of induction, as determined by plaquing on HFF monolayers.
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down-regulation of these tachyzoite-specific genes in exotic
strains MAS and FOU following culture under bradyzoite-
inducing conditions (Fig. 3). All of the strains turned on the
bradyzoite gene BAG1 strongly under inducing conditions,
while only FOU failed to induce the bradyzoite-specific gene
LDH2 (Fig. 3). In summary, these results indicate that, while
exotic strains are able to induce some bradyzoite markers, they
are defective in down-regulating tachyzoite genes following
culture under conditions that normally induce differentiation.
In vitro development of pepsin-resistant parasites. The rel-
ative resistance to acid-pepsin was used as a criterion to eval-
uate the in vitro production of bradyzoites (17). The number of
resistant parasites was determined by plaquing on host cell
monolayers after pepsin treatment and neutralization. The
clonal lineages expressed pepsin-resistant parasites at levels
that ranged between 3 and 9% of all viable parasites (Table 3).
Similar levels were observed for the exotic strains GPHT,
CAST, and COUG (Table 3). However, the exotic strains MAS
and FOU proved very inefficient at producing pepsin-resistant
forms in vitro (Table 3). The failure of MAS and FOU to
express pepsin resistance is consistent with their impaired abil-
ity to express bradyzoite antigens and suggests they are defec-
tive in cyst production in vitro.
Ultrastructure of cysts formed in vitro. The tissue cysts
formed by T. gondii have a characteristic thin, convoluted wall
underlain by granular material that also fills the lumen (20).
Bradyzoites show several subtle morphological differences
from tachyzoites, including the presence of amylopectin
FIG. 2. Expression of cyst antigens following in vitro differentiation of T. gondii strains. The majority of strains strongly express both the cell
wall epitope detected by DBL (green) and the CST-1 antigen (red). However, MAS expressed both markers poorly and FOU failed to stain with
DBL, while staining positively for CST-1. At 5 days postinduction, the cells were fixed and stained with fluoresceinated DBL (green) and antibody
to CST-1 followed by goat anti-mouse IgG conjugated to Alexa 594 (red). Nuclei are stained in blue. Scale bar  10 m. All pictures shown were
recorded under similar optical conditions, imaged with the same exposure time, and processed identically.
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granules, a posteriorly positioned nucleus, more abundant
micronemes, and electron-dense rhoptries (20, 22). Conse-
quently, we examined cysts formed in vitro for these diagnostic
features. Following 5 to 9 days of in vitro culture at an alkaline
pH, cysts were fixed and processed for conventional electron
microscopy. Cysts of the ME49 strain showed a characteristic
thin, convoluted cell wall containing a granular matrix (Fig. 4).
Parasites within these cysts displayed the hallmark features
of bradyzoites, including a posterior nucleus, solid-staining
rhoptries, amylopectin granules, and an increased number of
micronemes (Fig. 4A and B). Similar morphological features
were exhibited by in vitro-derived bradyzoites of other clonal
strains (i.e., GT-1 and CTG) and the exotic strains GPHT,
COUG, and CAST (data not shown). In contrast, the exotic
strains MAS and FOU exhibited features more similar to those
of tachyzoites, including a centrally positioned nucleus, fewer
micronemes, and rhoptries with a honeycombed appearance
(Fig. 4C and D). Despite these tachyzoite-like features, the
parasites were contained in a morphologically normal cyst wall
(Fig. 4). These features are consistent with a reduced ability to
differentiate in vitro under stress conditions.
Strains of T. gondii produce very different sizes of cysts in
vivo. The failure of several exotic strains to develop cysts in
vitro suggested that they may also be deficient in vivo. Conse-
quently, we infected mice or rats with different strains of T.
gondii and examined the development of cysts in vivo (Table
4). In vivo-derived cysts were examined for average size and
staining intensity with fluoresceinated DBL (Fig. 5). The clonal
strain GT-1 stained strongly with DBL, although it exhibited a
somewhat different pattern of staining, with the lectin-positive
material often being found within the cyst rather than primarily
on the wall (Fig. 4). MAS produced normal-looking cysts in
vivo, and thus, the failure to develop mature bradyzoites in
vitro is due to a reduced responsiveness to the stress induction
conditions, rather than an inherent defect in bradyzoite for-
mation. We failed to detect DBL-positive or BAG1-positive
cysts in mice or rats that were infected with FOU, suggesting
that it is highly defective in differentiation. While cyst sizes
FIG. 3. qPCR analysis of stage-specific genes during in vitro differentiation of T. gondii. Parasites were cultured in vitro under conditions that
induce differentiation. After 5 days, total RNA was harvested and analyzed by qPCR for the stage-specific genes shown. The ME49 and COUG
strains showed strong repression of the tachyzoite-specific genes SAG1 and SAG2A, while strains MAS and FOU continued to express these genes
at levels typical of tachyzoites. All strains showed induction of the bradyzoite-specific gene BAG1, and all strains except FOU showed induction
of LDH2. The values represent the fold change based on CT comparison (see Materials and Methods).
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ranged from 10 to 	60 m in diameter for all strains, there
were significant differences in the average sizes of the strains
(Table 4). Notably, strains such as ME49 and COUG produced
relatively large cysts, while MAS, GPHT, and CAST produced
much smaller cysts. When the different diameters were used to
calculate the average volumes (assuming a spherical shape),
the magnitudes of these differences in comparison to the av-
erage volume of ME49 were even more apparent (Table 4).
FIG. 4. Electron microscopy of T. gondii cysts formed after 9 days of induction in vitro. (A) Intracellular cyst of ME49 demonstrating the convoluted cell
wall (arrows) and internal granular matrix (M). Parasite nuclei (N) are located posteriorly. (B) Enlargement of ME49 cyst demonstrating posterior nuclei (N),
abundant micronemes (black arrowheads), amylopectin granules (arrows), and electron-dense rhoptries (white arrowheads). (C) Cyst of MAS containing
parasites that resemble tachyzoites. Although the cyst wall (arrows) and internal matrix (M) were similar, the parasites lacked features of bradyzoites. Parasite
nuclei (N) were located centrally. (D) Enlargement of MAS cyst showing parasites with honeycombed rhoptries (white arrowhead), centrally located nucleus (N),
fewer micronemes, and fewer amylopectin granules. (E) Cyst of FOU showing tachyzoite-like features, including centrally located nucleus (N) and honeycombed
rhoptries (arrowhead). (F) Enlarged cyst of FOU showing characteristic tachyzoite-like features, including centrally located nuclei (N), fewer micronemes, and
absence of amylopectin granules. Scale bars in A and C  1 m; scale bars in B, D, E, and F  500 nm.




arch 10, 2014 by W







Collectively, these results indicate that reduced oral transmis-
sion may be due to failure to induce proper cyst formation
(e.g., FOU) or the production of small cysts containing fewer
bradyzoites (e.g., MAS, CAST, and GPHT).
Oral transmission of strains of T. gondii. There was a strong
correlation between the size of cysts produced in vivo and oral
transmission (Table 4). As reported previously, oral challenge
of mice with 5 to 10 cysts of the clonal lineages (ME49, GT-1,
and CTG) led to 40% of animals becoming infected (Table
4). We have previously reported that oral challenge of mice
with tissue cysts of the exotic strain MAS fails to result in
infection (39). Consistent with that report, we observed here
that this strain produced cysts in rats, yet these stages failed to
cause oral infection when administered to mice (Table 4 and
data not shown). CAST is also impaired in oral transmission,
although this defect can be overcome by greatly increasing the
challenge dose (39). The exotic strains FOU and GPHT are
highly virulent in mice; hence, rats, which are naturally resis-
tant to T. gondii, were chronically infected (32). We were
unable to produce cysts in vivo for strain FOU, as it appears to
be defective in differentiation. Repeated subinoculation with
brain homogenates from infected rats also failed to cause in-
fection by either the oral or i.p. route in naı¨ve mice, suggesting
that the animals did not maintain a chronic infection despite
being seropositive (Table 4). Mice challenged by the oral route
with 5 to 10 cysts of GPHT became infected with very low
efficiency, comparable to that of CAST (Table 4 and data not
shown). These results indicate that GPHT is also deficient in
direct oral transmission, likely due to the smaller sizes of cysts
produced in chronically infected animals.
DISCUSSION
We compared the abilities of clonal versus exotic strains of
T. gondii to differentiate in vitro into bradyzoites and to cause
oral infection in the mouse, a model intermediate host. Mem-
bers of all three clonal lineages demonstrated efficient induc-
tion of bradyzoite markers in vitro, including the expression of
stage-specific antigens, ultrastructural changes, resistance to
acid-pepsin, and oral transmission to mice. In contrast, a num-
ber of exotic lineages were partially defective in the formation
of cysts, resulting in a reduced ability to transmit between
intermediate hosts via the oral route. Defects in the exotic
strains included the formation of fewer and smaller cysts and,
in some cases, an inability to undergo efficient differentiation in
vitro. Collectively, these studies reveal that efficient oral trans-
mission of T. gondii may be due to rapid differentiation in
response to stress leading to the production of larger and more
numerous tissue cysts. While these features are shared by the
clonal lineages and some exotic strains (i.e., COUG), they are
lacking in several exotic strains studied here.
TABLE 4. Comparison of in vivo-derived cysts of clonal













GT-1 I 100† 39
 18 38 50†
ME49 II 40 54
 18 100 100
CTG III 40 41
 15 44 47
COUG Exotic 73 59
 18 130 80
CAST Exotic 100† 29
 11 16 10†
GPHT Exotic 100† 23
 5.6 12 11†
MAS Exotic 100† 17
 13 3 0
FOU Exotic 100† ND ND 0
a Cumulative rates of mortality of mice following i.p. challenge with
tachyzoites. Shown are percentages of positive mice based on mortality (†) or
seropositive survivors. The data in this column are summarized from reference
39, with the addition of new data for FOU and GPHT.
b Measured from 10 to 15 separate cysts. ND, not done.
c Determined by the standard geometric formula for a sphere based on the
average diameter and normalized to the average volume of ME49. ND, not done.
d CD-1 outbred mice were challenged orally with 5 to 10 cysts isolated from
chronically infected mouse or rat brain. Shown are percentages of positive mice
that died (†) or percentages of seropositive survivors. The data in this column are
summarized from reference 39, with the addition of new data for GPHT.
FIG. 5. In vivo-derived cysts of T. gondii stained with DBL. All strains of T. gondii produced cysts in vivo that stained strongly with lectin (white
areas). Brain homogenates from chronically infected mice or rats were fixed and stained with fluoresceinated lectin. Scale bars  10 m.
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Representative strains of all three clonal lineages demon-
strated efficient expression of bradyzoite markers following in
vitro induction with alkaline pH-induced stress. Stage conver-
sion was evident from increased expression of the bradyzoite
antigen BAG1 (42), with a corresponding decrease in the
tachyzoite surface antigen SAG1 (8). This evidence was par-
alleled by the qPCR data showing the coordinate expression of
tachyzoite genes (i.e., SAG1and SAG2A) in tachyzoites and the
induction of bradyzoite genes (i.e., BAG1and LDH2) following
the induction of cyst differentiation. The cysts stained posi-
tively with DBL, expressed the cyst wall antigen CST1 (44),
and had ultrastructural features consistent with bradyzoites
(14). These features are similar to previous reports of in vitro
development of bradyzoites by the type II ME49 strain (5, 6,
37, 38). Our findings are notable, since they demonstrate a
similar capacity for stage conversion among all three clonal
lineages. We also demonstrate that in vitro-differentiated
bradyzoites acquire pepsin resistance and are orally infectious
when used to challenge mice. All three clonal strains tested
here were comparable in their ability to form fully mature
bradyzoites and induce oral infection in the mouse. These
results may be dependent in part on the use of low-passage
isolates, as we have observed that long-term maintenance of
strains in in vitro culture results in the down-regulation of this
differentiation pathway, especially in the type I lineage (un-
published data).
The relative infectivity of in vitro-derived bradyzoites com-
pares favorably with bradyzoites found within tissue cysts that
develop in the brains of chronically infected mice. Following in
vitro culture for 9 days in alkaline pH medium, 1,000 DBL
cysts were required to reliably infect 50% of mice by the oral
route. Only a portion of the cysts formed in vitro contained
pepsin-resistant parasites (10%), and these cysts generally
contained 10 to 20 bradyzoites, as judged by DAPI staining
(data not shown). Hence, the infectivity of in vitro-derived
bradyzoites compares favorably with the infectivity of brady-
zoites derived from mouse brain cysts (15). In contrast,
tachyzoites are sensitive to pepsin, and hence it requires 	106
of these parasites to cause oral infection in the mouse (17). In
comparing our results to those of these previous studies, we
conclude that (i) a portion (i.e., 10%) of the bradyzoites
within cysts formed in vitro are fully mature as defined by oral
infectivity, (ii) maturation increases with the length of devel-
opment, and (iii) in vitro-derived bradyzoites have approxi-
mately the same infectivity via the oral route as tissue cyst-
derived bradyzoites. In vitro-derived-bradyzoites provide an
attractive alternative for studying transmission dynamics and
gene expression during development and for screening for new
inhibitors that may disrupt parasite chronicity.
The exotic strain COUG shares the efficient induction of
bradyzoites in vitro with the clonal lineages, and cysts pro-
duced by this strain were equally infectious by the oral route.
However, the four other exotic strains studied here showed
partial or complete defects in this process that may explain
their underlying differences in oral transmissibility. These de-
fects can be grouped into two processes, underdevelopment
and ineffective differentiation, as summarized here and further
defined below. The exotic strains CAST, GPHT, and MAS
were less efficient at forming cysts in vivo and produced smaller
cysts with fewer parasites. Additionally, the two exotic strains
MAS and FOU showed more-severe defects that were refrac-
tory to the induction of bradyzoite transformation in vitro in
response to alkaline pH-induced stress. Collectively, these
traits are likely to result in less-efficient oral transmission be-
tween intermediate hosts.
The previously characterized exotic strain CAST has de-
creased oral transmission in the mouse model compared with
the clonal lineages (39). A similar phenotype was observed
here for the unrelated exotic strain GPHT. These two exotic
strains underwent normal differentiation in vitro following al-
kaline pH stress designed to induce bradyzoite development.
They efficiently expressed bradyzoite antigens (i.e., BAG1 and
DBL staining) and demonstrated ultrastructural features of
cysts. However, these strains formed small cysts in vivo and
failed to establish high tissue burdens, unlike the clonal lin-
eages. Exotic strains MAS and FOU also produced small cysts
that were low in number. Because the dose of bradyzoites
necessary to cause oral infection in the mouse model is rela-
tively high, i.e., 1,000 bradyzoites (15), the inefficient oral
transmission of these strains may result from a low tissue
density of bradyzoites. Differentiation is also likely to be influ-
enced by passage history, and it is possible that repeated pas-
sage of these strains in animals (as bradyzoites) might resus-
citate their defects in transmission. However, this process is
unlikely to rescue strains MAS and FOU, which are unable to
cause oral infection in rodents, thus precluding repeated pas-
sage as tissue cysts in vivo.
The exotic strains MAS and FOU also had more-profound
defects in differentiation. Following in vitro culture under
alkaline pH-induced stress, MAS and FOU were severely im-
paired in bradyzoite development. Both strains stained weakly
with DBL, indicating that they fail to develop a normal cyst
wall. The antigen recognized by mAb 73.18 to CST1 has been
described as the major glycoprotein in the cell wall, and the
reactivity of this mAb correlates with the results of DBL stain-
ing (44). The very weak staining of MAS with both DBL and
antibodies to CST1 suggests that it is defective in the expres-
sion of this antigen. On the other hand, FOU reacted abun-
dantly to mAb against CST1 despite staining only weakly with
DBL, suggesting that this cyst wall antigen lacks normal gly-
cosylation. Previous reports have indicated that the cell wall
stains with DBL (recognizing N-acetylgalactosamine) and with
succinylated wheat germ agglutinin (recognizing N-acetylglu-
cosamine) (7). We have not probed the cyst wall formed by
FOU and MAS with succinylated wheat germ agglutinin; how-
ever, these two strains might be useful for further studies to
define the assembly and composition of the cell wall. Despite
these defects, the cyst wall in these two strains appeared nor-
mal with ultrastructural examination and consisted of a con-
voluted cell wall and internal matrix. However, parasites within
the cyst-like vacuoles formed by these strains failed to demon-
strate ultrastructural features consistent with bradyzoites, but
instead resembled tachyzoites. Strains MAS and FOU also
failed to develop acid-pepsin resistance, consistent with a fail-
ure to undergo differentiation. This was further evident from
their failure to shut off tachyzoite gene expression, as shown by
qPCR. Collectively, these features indicate that MAS and
FOU fail to differentiate in vitro in response to alkaline pH-
induced stress. This defect would appear to result from an
inability to sense or respond to the stress response, which has
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been linked to differentiation (21, 41). In this regard, strains
MAS and FOU resemble knockout mutants lacking the P-type
(H) ATPase PMA1, which fail to respond to stress conditions
in vitro (24). However, since pma1 parasites still form cysts in
vivo that are orally infectious (24), the defect in MAS and
FOU must be more complex than a simple failure to respond
to stress-inducing signals for differentiation. Further analysis of
these exotic strains will be useful for exploring the pathways
of differentiation in response to environmental signals.
Our findings reveal that the defects in oral transmission of
some exotic strains relate to defects in differentiation in re-
sponse to stress and an inability to form large and abundant
cysts in vivo, in the mouse model. Variation in cyst size and
abundance may also occur in other intermediate hosts, which
would be expected to influence transmission by the asexual
route in the wild. Large cysts likely enhance the transmission of
T. gondii between intermediate hosts, since bradyzoites are not
highly infectious by this route. Notably, variations in size or
numbers may be less likely to influence oral transmission to
cats, since the threshold for such infections is much lower (14).
Consistent with this, strain MAS can be successfully transmit-
ted through a cat, with a short prepatent period characteristic
of bradyzoite infection, despite not being efficient in transmis-
sion between intermediate hosts (unpublished result). Previous
studies using chemically derived mutants that were selected for
an inability to differentiate suggest a hierarchy of control of
gene expression during differentiation (36). These mutants had
global defects in the expression of bradyzoite-specific genes,
although variations in specific genes were observed between
separate mutants. Because so many genes were affected in
these mutants, it is difficult to identify the precise role of any
one gene in altering traits such as transmission. In contrast, the
naturally occurring strains examined here appear to have more
subtle defects in differentiation, as they could still express early
bradyzoite markers (BAG1, LDH2, and cyst wall antigens).
Further molecular comparison of the strains described here
may reveal more specific defects that affect differentiation and
oral transmission, which is likely to be informative about the
evolutionary forces that have shaped transmission dynamics in
T. gondii.
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